Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Patent tenofovir alafenamide gilead?Allergan's patent for latisse expired?Dabrafenib btd date 2023?Mebendazole 100mg price?
See the DrugPatentWatch profile for Cladribine
Cladribine is sold under the brand name Mavenclad. The manufacturer for Mavenclad is Merck KGaA (EMEA) / Merck (US).
Mavenclad is marketed in different regions by Merck’s affiliates, so the “manufacturer” on packaging can vary by jurisdiction even when the same product is involved. The most reliable way to identify the exact listed manufacturer in your market is to check the prescribing information or the label for your country’s version of Mavenclad.
Availability of generics (or company-to-company manufacturing for specific markets) depends on local approvals and patent/exclusivity status. For cladribine, the branded product is tied to Merck’s commercial and patent position. For the latest patent/exclusivity and competing company signals, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
If you need to confirm the correct manufacturer, look for: - The brand name (Mavenclad) and strength on the packaging - The “manufacturer” and “marketing authorization holder” listed on the local product label - The prescribing information for the specific country version of Mavenclad
Cladribine manufacturers can differ on the paperwork between regions (affiliate vs. actual production site). If you share the country (or the exact product label text you have), I can help identify which manufacturer name applies there. Sources: 1. DrugPatentWatch.com
Other Questions About Cladribine :